Английская Википедия:BQ-123

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Chembox

BQ-123, also known as cyclo(-D-Trp-D-Asp-Pro-D-Val-Leu-), is a cyclic pentapeptide that was first isolated from a fermentation broth of Streptomyces misakiensis in 1991.[1] NMR studies indicate that the polypeptide backbone consists of a type II beta turn and an inverse gamma turn.[2][3] The side-chains adopt different orientations depending on the solvent used.[4][5] The proline carbonyl oxygen atom located at the onset of a beta turn is a sodium ion binding site.[6] It has a high affinity for sodium ions and can coordinate up to three of them.[7] Studies have shown that BQ123 is effective in reversing Ischemia-induced acute renal failure, and it has been suggested that this might be because BQ123 increases reabsorption of sodium ions in the proximal tubule cells.[8][9][10][11][12]

BQ-123 is a selective ETA endothelin receptor antagonist.[13][14] As such, it is used as a biochemical tool in the study of endothelin receptor function. BQ-123 works as an ET-1 antagonist by reversing already established contractions to ET-1. This indicates that BQ-123 can work as an antagonist to remove ET-1 from its receptor (ETA).[15]

References

Шаблон:Reflist

Шаблон:Portal bar


Шаблон:Biochem-stub